"Nasopharyngeal Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the NASOPHARYNX.
| Descriptor ID |
D009303
|
| MeSH Number(s) |
C04.588.443.665.710.650 C07.550.350.650 C07.550.745.650 C09.647.710.650 C09.775.350.650 C09.775.549.650
|
| Concept/Terms |
Nasopharyngeal Neoplasms- Nasopharyngeal Neoplasms
- Nasopharyngeal Neoplasm
- Neoplasm, Nasopharyngeal
- Neoplasms, Nasopharyngeal
- Nasopharynx Neoplasms
- Nasopharynx Neoplasm
- Neoplasm, Nasopharynx
- Neoplasms, Nasopharynx
Cancer of Nasopharynx- Cancer of Nasopharynx
- Nasopharynx Cancers
- Nasopharyngeal Cancer
- Cancer, Nasopharyngeal
- Cancers, Nasopharyngeal
- Nasopharyngeal Cancers
- Nasopharynx Cancer
- Cancer, Nasopharynx
- Cancers, Nasopharynx
- Cancer of the Nasopharynx
|
Below are MeSH descriptors whose meaning is more general than "Nasopharyngeal Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Nasopharyngeal Neoplasms".
This graph shows the total number of publications written about "Nasopharyngeal Neoplasms" by people in this website by year, and whether "Nasopharyngeal Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nasopharyngeal Neoplasms" by people in Profiles.
-
Rajasekaran N, Wang X, Ravindranathan S, Chin DJ, Tseng SY, Klakamp SL, Widmann K, Kapoor VN, Vexler V, Keegan P, Yao S, LaVallee T, Khare SD. Toripalimab, a therapeutic monoclonal anti-PD-1 antibody with high binding affinity to PD-1 and enhanced potency to activate human T cells. Cancer Immunol Immunother. 2024 Feb 24; 73(3):60.
-
Kwon HK, Han KD, Cheon YI, Shin SC, Lee M, Sung ES, Lee JC, Lee BJ. The incidence of myocardial infarction and stroke in head and neck cancer patients. Sci Rep. 2021 02 18; 11(1):4174.
-
Fareed MM, AlAmro AS, Bayoumi Y, Tunio MA, Ismail AS, Akasha R, Mubasher M, Al Asiri M. Intensity-modulated radiotherapy with simultaneous modulated accelerated boost technique and chemotherapy in patients with nasopharyngeal carcinoma. BMC Cancer. 2013 Jul 01; 13:318.
-
Kwee SA, DeGrado TR, Talbot JN, Gutman F, Coel MN. Cancer imaging with fluorine-18-labeled choline derivatives. Semin Nucl Med. 2007 Nov; 37(6):420-8.
-
Zhu K, Levine RS, Brann EA, Hall HI, Caplan LS, Gnepp DR. Case-control study evaluating the homogeneity and heterogeneity of risk factors between sinonasal and nasopharyngeal cancers. Int J Cancer. 2002 May 01; 99(1):119-23.
-
Lin TM, Chang HJ, Chen CJ, Cheng YJ, Yang CS, Tu SM, Ito Y, Kawamura A, Hirayama T. Risk factors for nasopharyngeal carcinoma. Anticancer Res. 1986 Jul-Aug; 6(4):791-6.
-
Lynn TC, Tu SM, Kawamura A. Long-term follow-up of IgG and IgA antibodies against viral capsid antigens of Epstein-Barr virus in nasopharyngeal carcinoma. J Laryngol Otol. 1985 Jun; 99(6):567-72.
-
Takada M, Murata M, Takei M, Nakagawa S, Okumura H, Kawamura A. The rescue of Epstein--Barr virus from primary cultured cells of nasopharyngeal carcinoma. Comp Immunol Microbiol Infect Dis. 1979; 2(2-3):177-89.
-
Sawaki S, Kawamura A, Tachibana T. Use of immunological studies in evaluating the clinical course of nasopharyngeal carcinoma. IARC Sci Publ (1971). 1978; (20):575-85.
-
Chen HC, Kawamura A, Murata M, Hamajima K, Osono M, Suzuki K, Sudo K. A histopathological study of lymphoid tissue reaction to metastatic nasopharyngeal carcinoma in nude mice. IARC Sci Publ (1971). 1978; (20):65-84.